KYDVARIX
LIVE

Serial Number

99723649

Owner

GlaxoSmithKline Biologicals SA

Attorney

Christopher M. Hanes

Filing Date

Mar 25, 2026

Add to watchlist:

No watchlists yet
View on USPTO

KYDVARIX Trademark

Serial Number: 99723649

KYDVARIX is a trademark filed by GlaxoSmithKline Biologicals SA on March 25, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

GlaxoSmithKline Biologicals SA (151 trademarks)

Rue de l'Institut 89
B-1330 Rixensart , BE

Entity Type: 99

Trademark Details

Filing Date

March 25, 2026

Registration Date

Not Registered

Published for Opposition

September 8, 2026

Goods & Services

Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 10, 2026 CNSA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 22, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 22, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 22, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 22, 2026 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 22, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 22, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 22, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 14, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jun 14, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jun 14, 2026 CNRT
ASSIGNED TO EXAMINER
Jun 12, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 25, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 25, 2026 NWOS
NEW APPLICATION ENTERED
Mar 25, 2026 NWAP